Nantong Jinghua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Nantong Jinghua Pharmaceutical Co Ltd cash flow-to-debt ratio. Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of CN¥97.93 Million could theoretically repay 0% of its total liabilities (CN¥393.50 Million) in one year. Check Nantong Jinghua Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Cash flow-to-debt ratio of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. Historical debt coverage capacity for Nantong Jinghua Pharmaceutical Co Ltd across 20 annual periods. Check 002349 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Nantong Jinghua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2006–2025)
Nantong Jinghua Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Nantong Jinghua Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Nantong Jinghua Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.81x | CN¥340.87 Million | CN¥421.13 Million | ▼ -10.3% |
| 2024 | 0.90x | CN¥311.02 Million | CN¥344.66 Million | ▲ +17.9% |
| 2023 | 0.77x | CN¥291.31 Million | CN¥380.75 Million | ▼ -10.8% |
| 2022 | 0.86x | CN¥358.39 Million | CN¥417.93 Million | ▲ +76.4% |
| 2021 | 0.49x | CN¥305.57 Million | CN¥628.54 Million | ▼ -0.9% |
| 2020 | 0.49x | CN¥328.22 Million | CN¥669.29 Million | ▲ +36.4% |
| 2019 | 0.36x | CN¥285.38 Million | CN¥793.62 Million | ▲ +204.0% |
| 2018 | 0.12x | CN¥83.43 Million | CN¥705.27 Million | ▼ -7.4% |
| 2017 | 0.13x | CN¥75.92 Million | CN¥594.47 Million | ▼ -91.5% |
| 2016 | 1.51x | CN¥343.80 Million | CN¥227.87 Million | ▲ +640.4% |
| 2015 | -0.28x | CN¥-76.01 Million | CN¥272.27 Million | ▼ -315.0% |
| 2014 | 0.13x | CN¥45.70 Million | CN¥351.96 Million | ▲ +177.8% |
| 2013 | -0.17x | CN¥-54.94 Million | CN¥328.99 Million | ▼ -152.5% |
| 2012 | 0.32x | CN¥77.25 Million | CN¥242.84 Million | ▲ +10.7% |
| 2011 | 0.29x | CN¥41.45 Million | CN¥144.23 Million | ▼ -53.1% |
| 2010 | 0.61x | CN¥41.06 Million | CN¥66.96 Million | ▼ -11.6% |
| 2009 | 0.69x | CN¥57.76 Million | CN¥83.26 Million | ▲ +213.0% |
| 2008 | 0.22x | CN¥17.13 Million | CN¥77.29 Million | ▼ -29.2% |
| 2007 | 0.31x | CN¥33.86 Million | CN¥108.25 Million | ▲ +80.8% |
| 2006 | 0.17x | CN¥22.18 Million | CN¥128.18 Million | — |